Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.

Cancer Med · 2023 · PMC10557860 · PMID 37654198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to achieve significanceno p-value reported

Although EBV also failed to achieve significance, it is regarded as a promising biomarker for ICI treatment, considering its association with PD‐L1 overexpression and immune cell signaling. 8 In addition, the prevalence of PIK3CA mutations in EBV‐positive GCs may support dual targeting of PIK3CA mutations and PD‐1 inhibition.

also in 299 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.